Latest filing published 17 Aug 2020 for CorMedix Inc., €8,611.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +21.5%Entry US$4.84 · Close at T+365 US$5.88
- +254.0%Entry US$2.72 · Close at T+365 US$9.63
- +5.0%Entry US$7.03 · Close at T+365 US$7.38
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Phoebe Mounts: trading record in brief
Phoebe Mounts discloses dealings in CorMedix Inc. to SEC (Form 4). In total, 3 filings cover trades dated from 30 December 2019 to 13 August 2020.
Purchases make up the whole of the open-market record (3 purchases, €27k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2020, the count stands at 3 purchases and no sales.
Half of the purchases are above €8,971 and half below. On 3 out of 3 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 67% of cases; the median change was +19.6%. They describe history only and say nothing certain about the share price ahead.
The record was last updated on 17 August 2020 with an open-market purchase (€8,611) in CorMedix Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Phoebe Mounts
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,525 shares@ US$4.0332.4% of flowCommon StockSEC:0001213900-20-022568:0Canonical exit: 11 Nov 2020 (T+90)
- 3,250 shares@ US$3.0533.9% of flowCommon StockSEC:0001213900-20-006882:0Canonical exit: 16 Jun 2020 (T+90)
- 1,425 shares@ US$7.0433.8% of flowCommon StockSEC:0001213900-20-000069:0Canonical exit: 29 Mar 2020 (T+90)
3 of 3 declarations
